Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Heather, Daley"'
Autor:
Terese C. Hammond, Marco A. Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow, Heather Daley, Kit Shaw, Koen van Besien, Alexandra Gomez-Arteaga, Don Stevens, Waldo Ortuzar, Xavier Michelet, Rachel Smith, Darrian Moskowitz, Reed Masakayan, Burcu Yigit, Shannon Boi, Kah Teong Soh, John Chamberland, Xin Song, Yu Qin, Ilya Mishchenko, Maurice Kirby, Valeriia Nasonenko, Alexa Buffa, Jennifer S. Buell, Dhan Chand, Marc van Dijk, Justin Stebbing, Mark A. Exley
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Invariant natural killer T (iNKT) cells, a unique T cell population, lend themselves for use as adoptive therapy due to diverse roles in orchestrating immune responses. Originally developed for use in cancer, agenT-797 is a donor-unrestricte
Externí odkaz:
https://doaj.org/article/d15d9c3789204f0f9cbf46c7c032881d
Autor:
Tamara A. Sussman, Mariano Severgnini, Anita Giobbie-Hurder, Philip Friedlander, Scott J. Swanson, Michael Jaklitsch, Thomas Clancy, Laura A. Goguen, David Lautz, Richard Swanson, Heather Daley, Jerome Ritz, Glenn Dranoff, F. Stephen Hodi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundIn the era of immune checkpoint blockade, the role of cancer vaccines in immune priming has provided additional potential for therapeutic improvements. Prior studies have demonstrated delayed type hypersensitivity and anti-tumor immunity wi
Externí odkaz:
https://doaj.org/article/ba235126d5b84090b4b832fedad15dec
Autor:
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Publikováno v:
Blood Advances. 7:768-777
Relapsed and refractory multiple myeloma (RRMM) is a plasma cell neoplasm defined by progressively refractory disease necessitating chronic and increasingly intensive therapy. Despite recent advances, limited treatment options exist for RRMM. This si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1a9636028e8421071dae6dd97a1f3c
https://doi.org/10.1182/bloodadvances.2022007210
https://doi.org/10.1182/bloodadvances.2022007210
Autor:
Vincent T. Ho, Haesook T. Kim, Natalie Bavli, Martin Mihm, Olga Pozdnyakova, Matthias Piesche, Heather Daley, Carol Reynolds, Nicholas C. Souders, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Jerome Ritz, Glenn Dranoff, Robert J. Soiffer
Publikováno v:
Blood Advances, Vol 1, Iss 24, Pp 2269-2279 (2017)
Abstract: We report a clinical trial testing vaccination of autologous myeloblasts admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells after allogeneic hematopoietic stem cell transplantation (HSCT). Patients with myelo
Externí odkaz:
https://doaj.org/article/b9cd8c81fce84bbb89eabfa774379357
Autor:
Sarah Nikiforow, Jerome Ritz, Glenn Dranoff, Robert Soiffer, Donna S. Neuberg, Richard M. Stone, Nikhil C. Munshi, Kristen Cummings, Heidi DiPietro, Ilene Galinsky, Frédéric F. Lehmann, David E. Gilham, Charles L. Sentman, Jake Reder, Adam Schmucker, Joanina K. Gicobi, Helene Trebeden-Negre, Heather Daley, Lillian Werner, Joana Murad, Susanne H. Baumeister
Adverse Events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d52b4af268577644fbdd16e762a372
https://doi.org/10.1158/2326-6066.22536640
https://doi.org/10.1158/2326-6066.22536640
Autor:
Sarah Nikiforow, Jerome Ritz, Glenn Dranoff, Robert Soiffer, Donna S. Neuberg, Richard M. Stone, Nikhil C. Munshi, Kristen Cummings, Heidi DiPietro, Ilene Galinsky, Frédéric F. Lehmann, David E. Gilham, Charles L. Sentman, Jake Reder, Adam Schmucker, Joanina K. Gicobi, Helene Trebeden-Negre, Heather Daley, Lillian Werner, Joana Murad, Susanne H. Baumeister
NKG2D ligands are widely expressed in solid and hematologic malignancies but absent or poorly expressed on healthy tissues. We conducted a phase I dose-escalation study to evaluate the safety and feasibility of a single infusion of NKG2D-chimeric ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df2480e70034b22ffe5601199e92cef9
https://doi.org/10.1158/2326-6066.c.6548194.v1
https://doi.org/10.1158/2326-6066.c.6548194.v1
Autor:
Sarah Nikiforow, Jerome Ritz, Glenn Dranoff, Robert Soiffer, Donna S. Neuberg, Richard M. Stone, Nikhil C. Munshi, Kristen Cummings, Heidi DiPietro, Ilene Galinsky, Frédéric F. Lehmann, David E. Gilham, Charles L. Sentman, Jake Reder, Adam Schmucker, Joanina K. Gicobi, Helene Trebeden-Negre, Heather Daley, Lillian Werner, Joana Murad, Susanne H. Baumeister
NKG2D-CAR T Cell Product Transduction Assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd1242552015c56670520f4b44238469
https://doi.org/10.1158/2326-6066.22536649.v1
https://doi.org/10.1158/2326-6066.22536649.v1
Autor:
Erica B. Esrick, Amy Federico, Daniela Abriss, Myriam Armant, Kari Boardman, Christian Brendel, Marioara-Felicia Ciuculescu, Heather Daley, Colleen Dansereau, Augustine Fernandes, Matthew M. Heeney, David G. Justus, Pei-Chi Kao, Annette S. Kim, Donald B. Kohn, Leslie E. Lehmann, Donghui Liu, Wendy B. London, John P Manis, Theodore B. Moore, Emily Morris, Danilo Pellin, Ellen Proeung, Shanna Richard, Gavin D. Roach, Kit L. Shaw, Dayna Terrazas, Shanna L White, David A. Williams
Publikováno v:
Blood. 140:10665-10667
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e828f889a6fcfac4de9b7fcb45370915
https://doi.org/10.1182/blood-2022-169089
https://doi.org/10.1182/blood-2022-169089
Autor:
Steven P. Balk, Jerome Ritz, F. Stephen Hodi, Anita Giobbie-Hurder, Glenn Dranoff, Heather Daley, Christine Canning, Kenneth LeClair, David Nemer, Justice Clark, Yo Mizukami, Wanyong Zeng, Tetsuro Sasada, Simon Yue, Lianne Vriend, Nadia Alatrakchi, Phillip Friedlander, Mark A. Exley
Purpose: Invariant NKT cells (iNKT) are innate-like CD1d-restricted T cells with immunoregulatory activity in diseases including cancer. iNKT from advanced cancer patients can have reversible defects including IFNγ production, and iNKT IFNγ product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6add45574ebffc1917c584a05b2db739
https://doi.org/10.1158/1078-0432.c.6526206.v1
https://doi.org/10.1158/1078-0432.c.6526206.v1
Autor:
Steven P. Balk, Jerome Ritz, F. Stephen Hodi, Anita Giobbie-Hurder, Glenn Dranoff, Heather Daley, Christine Canning, Kenneth LeClair, David Nemer, Justice Clark, Yo Mizukami, Wanyong Zeng, Tetsuro Sasada, Simon Yue, Lianne Vriend, Nadia Alatrakchi, Phillip Friedlander, Mark A. Exley
Suppl. Figs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f87d74f2c78ea559057d964ffd051a4
https://doi.org/10.1158/1078-0432.22465992
https://doi.org/10.1158/1078-0432.22465992